Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the record history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.4.2 and removed notices about government funding lapse and Revision: v3.4.1.SummaryDifference0.4%

- Check70 days agoChange DetectedAdded a site-wide maintenance notice regarding funding lapse and current operating status with links to cc.nih.gov and opm.gov. Updated the page revision identifier to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check77 days agoChange DetectedGlossary visibility was added, change highlights use green for additions and red for deletions, and the revision label was updated from v3.3.4 to v3.4.0 with updated No FEAR Act wording.SummaryDifference0.5%

- Check91 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed, indicating a minor system update to the page's revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.